Pauls Dietrich John (CIK 1760123) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-12). Recent activity: Buy DMAC (60,200 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | DiaMedica Therapeutics Inc. (DMAC) | President & CEO | Buy | 60,200 | $0 |
Source: SEC Form 4 filings · as of 2026-08-12